Prosecution Insights
Last updated: August 17, 2026
Application No. 19/090,876

Precise Targeting in a Spinal Cord Stimulation System

Non-Final OA §102
Filed
Mar 26, 2025
Priority
Jun 02, 2021 — provisional 63/195,899 +1 more
Examiner
WU, TONG E
Art Unit
Tech Center
Assignee
Boston Scientific Corporation
OA Round
1 (Non-Final)
71%
Grant Probability
Favorable
1-2
OA Rounds
1y 6m
Est. Remaining
86%
With Interview

Examiner Intelligence

Grants 71% — above average
71%
Career Allowance Rate
471 granted / 665 resolved
+10.8% vs TC avg
Strong +16% interview lift
Without
With
+15.7%
Interview Lift
resolved cases with interview
Typical timeline
2y 11m
Avg Prosecution
30 currently pending
Career history
690
Total Applications
across all art units

Statute-Specific Performance

§101
4.5%
-35.5% vs TC avg
§103
36.0%
-4.0% vs TC avg
§102
16.7%
-23.3% vs TC avg
§112
28.0%
-12.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 665 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1-4, 7-19 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Annecchino (US 2021/0008371). Regarding claims 1, 9, 10, 16-19, Annecchino discloses the same invention as claimed, including a method of using an external device with a stimulator device having a plurality of electrodes forming an electrode array (abstract; Figures 2-4) comprising providing stimulation at a first location in the electrode array (Figure 25: 2520), receiving at a user interface of the external device a plurality of inputs for each of a plurality of body regions, wherein the plurality of inputs for each body region comprise a pain score and an indication of stimulation coverage in response to the provided stimulation (Figure 25: 2530, 2540; Paragraphs 9-10), determining using the plurality of inputs at least a direction from the first location in which the stimulation can be moved in the electrode array to better target the patient’s symptoms (Figure 25: 2550), and programming the stimulator device to move the stimulation to a second location in the electrode array in accordance with the direction (Figure 25: 2560). Regarding claims 2-4, 7, Annechino discloses computing a value for each of the body regions as recited (Figure 25: 2540). Regarding claim 8, Annechino discloses moving the stimulation with the external device as recited (Figure 24). Regarding claims 11-12, Annecchino discloses a direction and distance as recited (Paragraphs 129, 130, 180). Regarding claims 13-15, Annecchino discloses adjusting a stimulation parameter as recited (Paragraphs 129, 130, 180). Allowable Subject Matter Claims 5-6 objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Mann (US 6,622,048), Rigoard (US 2016/0220179), Sieracki (US 6,308,102) shows assessing pain score and paresthesia coverage for various body regions to adjust stimulation. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Eugene T Wu whose telephone number is (571)270-5053. The examiner can normally be reached M-F 8am-5pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Carl Layno can be reached on 571-272-4949. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /Eugene T Wu/Primary Examiner, Art Unit 3796
Read full office action

Prosecution Timeline

Mar 26, 2025
Application Filed
Jul 15, 2026
Non-Final Rejection mailed — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12678123
Multi-dimensional Artificial Intelligence Auscultation Device
2y 9m to grant Granted Jul 14, 2026
Patent 12673208
SYSTEM AND METHOD FOR TREATING CHRONIC PAIN
3y 0m to grant Granted Jul 07, 2026
Patent 12654016
Devices and Methods for Stimulating Neural Tissue
2y 7m to grant Granted Jun 16, 2026
Patent 12635914
PERSPIRATION AMOUNT MEASURING DEVICE AND PERSPIRATION AMOUNT MEASURING SYSTEM
2y 6m to grant Granted May 26, 2026
Patent 12629525
SYSTEM AND METHOD FOR CONTROLLING NEUROSTIMULATION ACCORDING TO USER ACTIVITY AND AUTOMATED RESCHEDULING OF STIMULATION PROGRAMS
3y 1m to grant Granted May 19, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
71%
Grant Probability
86%
With Interview (+15.7%)
2y 11m (~1y 6m remaining)
Median Time to Grant
Low
PTA Risk
Based on 665 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month